1. Home
  2. PGC vs ANNX Comparison

PGC vs ANNX Comparison

Compare PGC & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peapack-Gladstone Financial Corporation

PGC

Peapack-Gladstone Financial Corporation

HOLD

Current Price

$44.68

Market Cap

836.7M

Sector

Finance

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.18

Market Cap

873.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGC
ANNX
Founded
1921
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
836.7M
873.3M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
PGC
ANNX
Price
$44.68
$4.18
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$40.50
$16.50
AVG Volume (30 Days)
92.4K
2.7M
Earning Date
04-22-2026
05-11-2026
Dividend Yield
0.48%
N/A
EPS Growth
13.51
N/A
EPS
1.65
N/A
Revenue
$282,995,000.00
N/A
Revenue This Year
$32.39
N/A
Revenue Next Year
$12.64
$16,320.74
P/E Ratio
$27.38
N/A
Revenue Growth
24.05
N/A
52 Week Low
$24.71
$2.54
52 Week High
$49.14
$7.18

Technical Indicators

Market Signals
Indicator
PGC
ANNX
Relative Strength Index (RSI) 43.70 39.34
Support Level $44.85 $3.79
Resistance Level $47.32 $5.63
Average True Range (ATR) 0.94 0.21
MACD -0.05 -0.00
Stochastic Oscillator 32.39 37.35

Price Performance

Historical Comparison
PGC
ANNX

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: